Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Filings indexed 812 across all filing types
Latest filing 2024-06-10 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
LIFE Improved read out distance for sensor preparing for longevity trials in dogs
Regulatory Filings Classification · 1% confidence The document is a press release dated June 10th, 2024, from Lifecare ASA announcing a technical development (improved sensor read-out distance) and stating readiness to start a longevity study in dogs. It references previous communications in the 'Q1 reporting' but does not contain the full Q1 report itself. The content focuses on operational progress, product development milestones, and upcoming studies, which is typical of a general operational update or news release. Since it is not a formal regulatory filing like a 10-K, a specific financial report (IR, MRQ), or a formal announcement of a meeting/vote, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were tied to a specific reporting period's results, but it's more of a progress update. Given the nature of announcing operational milestones and referencing MAR Article 19, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback category for this type of corporate news release that doesn't fit a more specific operational or financial code.
2024-06-10 English
Lifecare ASA: Mandatory notification of trade
Major Shareholding Notification Classification · 1% confidence The document is titled "LIFECARE ASA: MANDATORY NOTIFICATION OF TRADE" and explicitly details a transaction (sale of subscription rights) by an individual closely associated with a board member (Trine Teigland). This type of insider transaction reporting falls directly under the definition of Director's Dealing (DIRS). Although it mentions an attachment (PDMR-form), the core content is the mandatory notification itself, not just an announcement of a report's publication. The length (1763 chars) is short, but the content is a specific regulatory disclosure about insider trading, making DIRS a better fit than RPA or RNS.
2024-06-07 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 1% confidence The document text details a transaction involving a person closely associated with a board member (Trine Teigland, a primary insider in Lifecare ASA). Specifically, it reports the 'Sale of subscription rights in rights issue' by 'Teigland Eiendom AS'. This structure—reporting personal share transactions by directors and executives—is characteristic of insider dealing disclosures. The closest matching category is 'Director's Dealing' (DIRS). It is not a general regulatory filing (RNS) because it fits a specific insider transaction category, nor is it a capital change announcement (SHA) as it reports the disposal of rights by an insider, not a general corporate action.
2024-06-07 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 1% confidence The document is titled 'Lifecare ASA: Mandatory notification of trade' and explicitly states that a company closely associated with a board member sold subscription rights in a Rights Issue. It refers to an attached PDMR-form (Primary Director/Manager/Insider form) for details. This content directly relates to personal share transactions by company directors or closely associated persons, which aligns perfectly with the definition of Director's Dealing (DIRS). The short length and focus on a specific transaction by an insider confirm this classification over a general Regulatory Filing (RNS).
2024-06-07 English
Lifecare ASA: Last day of trading in Subscription Rights
Capital/Financing Update Classification · 1% confidence The document is an announcement titled "LIFECARE ASA: LAST DAY OF TRADING IN SUBSCRIPTION RIGHTS". It details the final day for trading subscription rights related to a previously announced Rights Issue, referencing a Prospectus and setting deadlines for subscription. This type of announcement, concerning capital structure changes, fundraising activities (Rights Issue), and associated security trading deadlines, fits best under the Capital/Financing Update category. Although it is an announcement, it is specifically about a financing event rather than just the publication of a general report, making 'CAP' more precise than 'RPA' or 'RNS'. The document explicitly discusses the Rights Issue, Subscription Price, Warrants, and the Manager, all elements of a capital raising event.
2024-06-07 English
Lifecare ASA: Last day of trading in Subscription Rights
Report Publication Announcement Classification · 1% confidence The document is an announcement from Lifecare ASA regarding the 'Last day of trading in Subscription Rights' related to a Rights Issue. It details the terms of the Rights Issue, the trading period for the Subscription Rights, and references a Prospectus. The disclosure regulation section explicitly states the information is published in accordance with requirements for companies listed on Euronext Growth Oslo and the Norwegian Securities Trading Act, and it was submitted for publication at a specific time. This type of announcement, concerning capital structure changes (Rights Issue) and regulatory disclosure deadlines, fits best under 'Capital/Financing Update' (CAP) or potentially a general 'Regulatory Filing' (RNS). Since the core subject is the mechanics and deadlines of a rights issue (a financing activity), CAP is the most specific fit. It is not a full report (10-K, IR), a management discussion (MDA), or a proxy statement (DEF 14A/PSI).
2024-06-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.